Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/844"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label | |
| rdf:type | |
| ?:Evidence_dose | |
| ?:Evidence_enzyme_system | |
| ?:Evidence_type | |
| ?:Evidence_value |
"0.000058"
|
| ?:content |
"route of administration: oral
study duration: "oral ziprasidone 40 mg/day, in two evenly divided daily doses, for 7 days, followed by a single 20 mg dose on day 8."
population: 35 participants including Eight young men, 11 young women (NOTE: three withdrew early on in the study), 8 elderly men and 8 elderly women where young is defined as 18-45 years of age and elderly is defined as (> or = 65 years). All participants were considered healthy and the majority were white.
tested for known CYP450 polymorphisms? NO
ages: see above
C_max @ 20mg single dose ziprasidone (average of combined young and old C_max from Table 2): (56 + 60) / 2 = 58ng/mL
58ng/mL X 1g/10^9ng X 1000mL/1L = 0.000058g/L"
|
| dc:creator | |
| dc:date |
"06/22/2009 10:27:28"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ ziprasidone_maximum_concentration_continuous_value, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1235 }